AdvisorShares Investments »

Relmada Therapeutics shares owned by AdvisorShares Investments

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by AdvisorShares Investments from 13F filings

Historical chart of AdvisorShares Investments investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by AdvisorShares Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by AdvisorShares Investments

Quarter filed Position value Share count Share price at filing
2023-09-30 $339k 113k 3.00
2023-06-30 $278k 113k 2.46
2023-03-31 $235k 104k 2.26
2022-12-31 $284k 81k 3.49
2022-09-30 $387k 11k 37.01

More positions owned by AdvisorShares Investments

Invesco Qqq Trust Series Adr (QQQ)
Spdr S&p 500 Etf Trust Adr (SPY)
First Trust Nasdq 100 Eq Adr (QQEW)
Terrascend Corp Common Stock (TSNDF)
Advisorshares Pure Us Can Adr (MSOS)
Miller Industries Inc/ten Adr (MLR)
Trex Company Adr (TREX)
Intuit Adr (INTU)
Fair Isaac Corp Adr (FICO)
Carrier Global Corp Common Stock (CARR)
Broadridge Financial Solu Adr (BR)
Celanese Corp Adr (CE)
Moody's Corp Common Stock (MCO)
Fiserv Adr (FI)
Stryker Corp Common Stock (SYK)

View all positions for AdvisorShares Investments

Top funds holding Relmada Therapeutics

Vanguard Group
Acadian Asset Management
Parsons Capital Management
Opaleye Management
Palo Alto Investors
Citadel Advisors
Two Sigma Advisers
Two Sigma Investments
Point72 Asset Management
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Bank of America Corporation
Millennium Management
Guild Investment Management
Marshall Wace

View all funds holding Relmada Therapeutics